
Cognition Therapeutics Inc (CGTX)’s latest performance is not what we had anticipated
On Monday, Cognition Therapeutics Inc (NASDAQ: CGTX) was -3.25% drop from the session before settling in for the closing price of $1.54. A 52-week range
On Monday, Cognition Therapeutics Inc (NASDAQ: CGTX) was -3.25% drop from the session before settling in for the closing price of $1.54. A 52-week range
Witnessing the stock’s movement on the chart, on Thursday, Cognition Therapeutics Inc (NASDAQ: CGTX) set off with pace as it heaved 36.07% to $1.66, before
On Monday, Cognition Therapeutics Inc (NASDAQ: CGTX) opened higher 13.81% from the last session, before settling in for the closing price of $0.75. Price fluctuations
As on Thursday, Cognition Therapeutics Inc (NASDAQ: CGTX) started slowly as it slid -4.78% to $0.68, before settling in for the price of $0.71 at
Cognition Therapeutics Inc (NASDAQ: CGTX) on Monday, soared 6.95% from the previous trading day, before settling in for the closing price of $0.67. Within the
Cognition Therapeutics Inc (NASDAQ: CGTX) open the trading on Thursday, with a bit cautious approach as it glided -5.85% to $0.59, before settling in for
A new trading day began on Monday, with Cognition Therapeutics Inc (NASDAQ: CGTX) stock price down -14.87% from the previous day of trading, before settling
Cognition Therapeutics Inc (NASDAQ: CGTX) established initial surge of 7.04% at $0.86, as the Stock market unbolted on Thursday, before settling in for the price
On Monday, Cognition Therapeutics Inc (NASDAQ: CGTX) opened higher 7.03% from the last session, before settling in for the closing price of $0.65. Price fluctuations
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.